Overview

• Under the definitive agreement, Joby will pay $90 million upfront in cash or stock and up to $35 million upon meeting employee retention and financial performance targets.
• Blade’s medical transport division will be carved out as a standalone company named Strata Critical Medical and will partner with Joby on organ-transport operations.
• Blade’s passenger operations will continue under CEO Rob Wiesenthal as a wholly owned subsidiary of Joby, preserving its brand and service network.
• The deal grants Joby control of Blade’s network of 12 urban terminals and access to a customer base that flew over 50,000 passengers in 2024.
• Joby remains on track to begin FAA Type Inspection flight testing of its electric vertical takeoff and landing aircraft early next year.